SINTX TECHNOLOGIES RENEWS LEASE WITH PORTFOLIO INVESTMENTS AT CENTREPOINTE BUSINESS PARK
June 10 2019 - 9:00AM
SINTX Technologies, Inc., a ceramics OEM company that develops and
manufactures silicon nitride, announced today that the Company
renewed its lease with Portfolio Investments at Centrepointe
Business Park in Salt Lake City, Utah, for a five year term. SINTX
has been at this location since 2009. The Company will lease a
smaller section of the building consistent with a new footprint
following the sale of its retail spine business and re-branding
last year.
Dr. Sonny Bal, President & CEO, said “This
is a milestone for SINTX. We have right-sized our operations, and
the significant cost savings from the building lease will allow
SINTX to focus on scaling up our manufacturing, and invest further
in R&D activities.”
“We are excited to remain in Salt Lake City, a
technology hub,” Dr. Bal added. “The company was founded here in
1996. Our first silicon nitride spinal device was implanted at the
University of Utah in 2008. We have long-standing relationships
with the University’s Bone & Joint Laboratory and Nanofab
facility. We look forward to growing our company in Utah.”
Centrepointe Business Park is located in
proximity of the Salt Lake City International Airport and is within
minutes of downtown Salt Lake City. Corey Brand of Centrepoint said
“SINTX has been a great tenant and we look forward to the next five
years with them.”
SINTX was represented in the transaction by
Travis Yates of Colliers International.
About SINTX TechnologiesSINTX
Technologies is an OEM ceramics company that develops and
commercializes silicon nitride for biomedical applications, such as
spine and dental implants. The core strength of SINTX Technologies
is the research and development of medical-grade silicon nitride
ceramics for external partners. The Company presently manufactures
silicon nitride spinal implants in its FDA registered and ISO 13485
certified manufacturing facility for CTL-Amedica, the exclusive
retail channel for silicon nitride spinal implants.
For more information on SINTX
Technologies or its silicon nitride material platform, please
visitwww.sintx.com.
Forward-Looking StatementsThis
press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
(“PSLRA”) that are subject to a number of risks and uncertainties.
Readers are cautioned not to place undue reliance on the
forward-looking statements, which speak only as of the date on
which they are made and reflect management’s current estimates,
projections, expectations and beliefs. A discussion of those risks
and uncertainties can be found in SINTX's Risk Factors disclosure
in its Annual Report on Form 10-K, filed with the Securities and
Exchange Commission (SEC) on March 11, 2019, and in SINTX's other
filings with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this report.
Contact:SINTX Technologies 801.839.3502 IR@sintx.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Aug 2024 to Sep 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Sep 2023 to Sep 2024